In a surprising move that has sent ripples through the UK pharmaceutical market, Eli Lilly has announced a temporary pause on orders of its diabetes drug Mounjaro ahead of an impending price increase. The company attributes the decision to concerns over stockpiling by healthcare providers and pharmacies, aiming to manage supply and demand more effectively amid rising costs. This development raises questions about access and affordability for patients relying on the medication, as stakeholders brace for the impact of the forthcoming price adjustment.
Eli Lilly Halts UK Mounjaro Shipments Ahead of Anticipated Price Increase
Eli Lilly has taken the unprecedented step of temporarily halting shipments of Mounjaro (tirzepatide) to the UK market, ahead of an expected price adjustment. The move comes amid growing concerns that customers and healthcare providers might engage in stockpiling, attempting to purchase larger quantities before the medication’s cost increases. This proactive…
—-
Author : Isabella Rossi
Publish date : 2025-08-28 20:55:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
